CClinicalTrials.gg
CompletedNCT05152511Updated Dec 10, 2021

Management of Post-circumcision Ischemia Using Hyperbaric Oxygen Therapy

An observational study in Post-circumsion Complications, sponsored by Aswan University Hospital. Completed at 1 site in Egypt. Open to male participants aged 1 Month to 6 Years. Per ClinicalTrials.gov, last updated 2021-12-10.

Sponsored by Aswan University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
23
Ages
1 Month to 6 Years
Sex
Male
01

Study summary

Background: Post-circumcision penile ischaemia is a rare but destructive complication. Our goal is to present our experience in the management of children, who had different forms of penile ischaemia, complicating the routine ritual male circumcision.

Material and Methods: All male children who had post-circumcision penile ischaemia between April 2017 and October 2020 were included in the study. A special designed protocol for management of all cases includes a combination of early Pentoxifylline intervenes infusion with Hyperbaric Oxygen inhalation, early catheterization, and appropriate surgical debridement. Data were analyzed inclusively to patient age, the anesthesia method used, Monopolar diathermy usage, early presentation, method of circumcision and positive wound culture.

Read the detailed description

It is a cohort prospective study. All male children who had penile ischaemia after circumcision were included in the study between April 2017 and October 2020. A special designed protocol includes early admission of a child in Paediatric intensive care unit (PICU). Catheterization by suitable size silicon Foley's catheter appropriate for the age. IV Pentoxifylline in a dose of 10 mg/kg/day divided into 3 equal doses with good monitoring of its side effects mainly tachycardia and convulsions. IV 3rd generation cephalosporin with suitable doses according to the age and body weight. Hyperbaric Oxygen therapy is a specially designed cabinet for infants and neonates with a barometric pressure equal to 760 mmHg for 20 minutes daily, then gradually increase up to one hour daily for 5 days per week (fig. 1). The chamber was kept warm. The babies were fed before entering the chamber and if signs of hunger appear during therapy. The baby was continuously monitored with pulse oximeter. Older children are managed in the conventional Hyperbaric Oxygen chamber with the same regimen. Proper surgical debridement together with daily topic dressing with nitroglycerin ointment (2%). The treatment continued through the admission period. Follow up period range from 6 months up to 3 years.

Data were analyzed inclusively to patient age, the type of medical provider who performed the circumcision, the technique of male circumcision, the anesthesia method used, if any Monopolar diathermy usage, wound suturing after MC, the duration of between male circumcision and presentation to our protocol, and the final condition of the patient at discharge and after 6 months.

02

Conditions studied

  • Post-circumsion Complications

Browse trials for

Keywords

  • Glans necrosis,
  • Hyperbaric oxygen,
  • Male Circumcision,
  • Pentoxifylline,
  • Monopolar cautery.
03

In context

Ischemia

2,058 studies on the registry are indexed under Ischemia; 347 are open to participants now.

This study's enrollment of 23 is below the median of 181 across 617 observational studies indexed under Ischemia.

Browse Ischemia studies →

Lead sponsor

Aswan University Hospital is the lead sponsor of 95 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 6 Years
Sexes eligible
Male
Sampling method
Probability sample

Study population

Twenty-three male children with penile ischaemia from 3076 post-circumcisions complicated patients.

Inclusion criteria

  • male children complained of penile ischaemia after circumcision.

Exclusion criteria

Exclusion Criteria:

  • other post-circumcision complication not include penile ischaemia
  • patients with chronic diseases.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
23 participants (actual)
Patient registry
No

Groups and cohorts

  • All male children who had penile ischaemia after circumcision were included in the study

    It is a cohort prospective study. All male children who had penile ischaemia after circumcision were included in the study between April 2017 and October 2020.

    Combination Product: Hyperbaric oxygen therapy

Interventions

  • Combination productHyperbaric oxygen therapy

    Hyperbaric oxygen therapy is a specially designed cabinet for infants and neonates with a barometric pressure equal to 760 mmHg for 20 minutes daily, then gradually increase up to one hour daily for 5 days per week (fig. 1). The chamber was kept warm. The babies were fed before entering the chamber and if signs of hunger appear during therapy. The baby was continuously monitored with pulse oximeter. Older children are managed in the conventional Hyperbaric oxygen chamber with the same regimen.

    Also known as: Pentoxifylline

06

What researchers measure

Primary outcomes

  1. post-circumcision complication

    early and late complication

    Time frame: April 2017 and October 2020

07

Study locations

1 site
  • Sarah Magdy Abdelmohsen
    Cairo, 11331, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05152511
Lead sponsor
Aswan University Hospital
Responsible party
Magdy (Principal Investigator, Aswan University Hospital) — Principal investigator
First posted
Dec 10, 2021
Start date
Apr 1, 2017
Primary completion
Oct 30, 2020
Completion
Oct 30, 2020
Last update
Dec 10, 2021

Study contacts

Sarah M Abdelmohsen
principal investigator · Aswan University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion